These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31495568)

  • 1. Reproducibility of the T-SPOT.TB test for screening Mycobacterium tuberculosis infection in Japan.
    Teranishi S; Kobayashi N; Aoki A; Katakura S; Yamamoto M; Koizumi H; Kudo M; Kaneko T
    J Infect Chemother; 2020 Feb; 26(2):194-198. PubMed ID: 31495568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-SPOT.TB Interferon-γ Release Assay Performance in Healthcare Worker Screening at Nineteen U.S. Hospitals.
    King TC; Upfal M; Gottlieb A; Adamo P; Bernacki E; Kadlecek CP; Jones JG; Humphrey-Carothers F; Rielly AF; Drewry P; Murray K; DeWitt M; Matsubara J; O'Dea L; Balser J; Wrighton-Smith P
    Am J Respir Crit Care Med; 2015 Aug; 192(3):367-73. PubMed ID: 26017193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of interferon-gamma release assay (T-SPOT.TB(™) ) for diagnosis of tuberculosis infection in rheumatic disease patients.
    Jiang B; Ding H; Zhou L; Chen X; Chen S; Bao C
    Int J Rheum Dis; 2016 Jan; 19(1):38-42. PubMed ID: 26820838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-γ release assay versus tuberculin skin test for monitoring TB infection in healthcare workers.
    Nienhaus A; Ringshausen FC; Costa JT; Schablon A; Tripodi D
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):37-48. PubMed ID: 23428101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance Evaluation of IGRA-ELISA and T-SPOT.TB for Diagnosing Tuberculosis Infection.
    Zhu M; Zhu Z; Yang J; Hu K
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the performance of two tuberculosis interferon gamma release assays (IGRA-ELISA and T-SPOT.TB) for diagnosing Mycobacterium tuberculosis infection.
    Wang L; Tian XD; Yu Y; Chen W
    Clin Chim Acta; 2018 Apr; 479():74-78. PubMed ID: 29325798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High reproducibility of the interferon-gamma release assay T-SPOT.TB in serial testing.
    Meier T; Enders M
    Eur J Clin Microbiol Infect Dis; 2021 Jan; 40(1):85-93. PubMed ID: 32770282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China.
    Wang MS; Wang JL; Wang XF
    BMC Pulm Med; 2016 Nov; 16(1):163. PubMed ID: 27887611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TST, QuantiFERON-TB Gold test and T-SPOT.TB test for detecting latent tuberculosis infection in patients with rheumatic disease prior to anti-TNF therapy.
    Sargın G; Şentürk T; Ceylan E; Telli M; Çildağ S; Doğan H
    Tuberk Toraks; 2018 Jun; 66(2):136-143. PubMed ID: 30246657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing an Interferon Gamma Release Assay with the Tuberculin Skin Test During Pregnancy: Implications for Tuberculosis Screening During Prenatal Care.
    Molina R; Venkatesh K; Schantz-Dunn J; Meadows A; Nour N; Diouf K
    Matern Child Health J; 2016 Jun; 20(6):1314-20. PubMed ID: 26645617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-Gamma Release Assay is Not Appropriate for the Diagnosis of Active Tuberculosis in High-Burden Tuberculosis Settings: A Retrospective Multicenter Investigation.
    Kang WL; Wang GR; Wu MY; Yang KY; Er-Tai A; Wu SC; Geng SJ; Li ZH; Li MW; Li L; Tang SJ
    Chin Med J (Engl); 2018 Feb; 131(3):268-275. PubMed ID: 29363640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon gamma release assays for monitoring the response to treatment for tuberculosis: A systematic review.
    Clifford V; He Y; Zufferey C; Connell T; Curtis N
    Tuberculosis (Edinb); 2015 Dec; 95(6):639-650. PubMed ID: 26515270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a New IFN-γ Release Assay for Rapid Diagnosis of Active Tuberculosis in a High-Incidence Setting.
    Li G; Li F; Zhao HM; Wen HL; Li HC; Li CL; Ji P; Xu P; Wu K; Hu ZD; Lu SH; Lowrie DB; Lv JX; Fan XY
    Front Cell Infect Microbiol; 2017; 7():117. PubMed ID: 28443247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic.
    Rose W; Read SE; Bitnun A; Rea E; Stephens D; Pongsamart W; Kitai I
    J Pediatric Infect Dis Soc; 2015 Jun; 4(2):96-103. PubMed ID: 26407408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges of interferon-γ release assay conversions in serial testing of health-care workers in a TB control program.
    Fong KS; Tomford JW; Teixeira L; Fraser TG; van Duin D; Yen-Lieberman B; Gordon SM; Miranda C
    Chest; 2012 Jul; 142(1):55-62. PubMed ID: 22796839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial T-SPOT.TB responses in Tanzanian adolescents: Transient, persistent and irregular conversions.
    Amour MA; Rees CA; Munseri PJ; Said J; Magohe AK; Matee M; Talbot EA; Arbeit RD; Pallangyo K; von Reyn CF
    PLoS One; 2022; 17(6):e0268685. PubMed ID: 35749397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High yield from repeated testing for tuberculosis among high-risk citizens in Denmark.
    Staerke NB; Smidt-Hansen T; Oldenborg L; Jensen TT; Weinreich UM; Shakar S; Wejse C; Hilberg O; Fløe A
    Int J Infect Dis; 2021 Jan; 102():352-356. PubMed ID: 33130208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.
    Costantino F; de Carvalho Bittencourt M; Rat AC; Loeuille D; Dintinger H; Béné MC; Faure G; Chary-Valckenaere I
    J Rheumatol; 2013 Dec; 40(12):1986-93. PubMed ID: 24085550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.